Cash flow Raymond James Financial, Inc.

Equities

RJF

US7547301090

Investment Banking & Brokerage Services

Market Closed - Nyse Other stock markets 01:30:02 11/04/2026 am IST			5-day change	1st Jan Change
146.19 ^USD	-1.32%		+2.81%	-8.97%

10/04	Autonomous Research Adjusts Price Target on Raymond James Financial to $189 From $193, Maintains Neutral Rating	MT
09/04	TD Cowen Adjusts Raymond James Financial PT to $156 From $181, Maintains Hold Rating	MT

0228d6bc.500YejEYNtjlsMDDr0v4e6IXI7QInmP97x9GMUy2Kbs.uCJSEG5Tfeqn2LqJ3D7IHZoga_pc-wS1uSgBWzjfXOGOEkBPaXJctKz6mQ

Published financial data: RAYMOND JAMES FINANCIAL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Interest and Dividend Income, Total	82Cr	150.8Cr	374.8Cr	423.2Cr	399.4Cr
Interest Expense, Total	15Cr	30Cr	137.3Cr	210.2Cr	184.7Cr
Net Interest Income	67Cr	120.3Cr	237.5Cr	213Cr	214.7Cr
Brokerage Commission	165.1Cr	158.9Cr	145.9Cr	165.1Cr	177.5Cr
Trading and Principal Transactions	56Cr	53Cr	46Cr	49Cr	53Cr
Asset Management Fee	486.8Cr	556.3Cr	536.3Cr	619.6Cr	707.8Cr
Underwriting & Investment Banking Fee	114.3Cr	110Cr	65Cr	86Cr	106.9Cr
Gain (Loss) on Sale of Investments, Total (Rev)	3.8Cr	90L	-	-	-20L
Other Revenues, Total	85Cr	91Cr	133.5Cr	151.5Cr	145.6Cr
Revenues Before Provison For Loan Losses	978.1Cr	1.09TCr	1.16TCr	1.28TCr	1.41TCr
Provision For Loan Losses	-3.2Cr	10Cr	13Cr	4.5Cr	3.7Cr
Total Revenues	981.3Cr	1.08TCr	1.15TCr	1.28TCr	1.4TCr
Salaries And Other Employee Benefits	658.3Cr	732.9Cr	721.7Cr	817.1Cr	903.7Cr
Cost of Services Provided, Total	101.4Cr	122.7Cr	140.5Cr	154.1Cr	172.5Cr
Other Operating Expenses	31Cr	32Cr	53Cr	37Cr	50Cr
Total Operating Expenses	790.9Cr	888.1Cr	915.4Cr	1.01TCr	1.13TCr
Operating Income	190.4Cr	192Cr	235.6Cr	271.7Cr	275.7Cr
Currency Exchange Gains (Loss)	-2.1Cr	10Cr	-2.3Cr	-2.1Cr	1.3Cr
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	188.3Cr	202.2Cr	233.3Cr	269.6Cr	277Cr
Restructuring Charges	-	-	-	-	-
Total Merger & Related Restructuring Charges	-1.9Cr	-	-8.5Cr	-5.3Cr	-5.6Cr
Gain (Loss) on Sale of Investments	2.5Cr	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Insurance Settlements	-	-	3.2Cr	-	-
Other Unusual Items	-9.8Cr	-	-	-	-
EBT, Incl. Unusual Items	179.1Cr	202.2Cr	228Cr	264.3Cr	271.4Cr
Income Tax Expense	39Cr	51Cr	54Cr	58Cr	58Cr
Earnings From Continuing Operations	140.3Cr	150.9Cr	173.9Cr	206.8Cr	213.5Cr
Net Income to Company	140.3Cr	150.9Cr	173.9Cr	206.8Cr	213.5Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	140.3Cr	150.9Cr	173.9Cr	206.8Cr	213.5Cr
Preferred Dividend and Other Adjustments	20L	70L	1.1Cr	90L	80L
Net Income to Common Incl Extra Items	140.1Cr	150.2Cr	172.8Cr	205.9Cr	212.7Cr
Net Income to Common Excl. Extra Items	140.1Cr	150.2Cr	172.8Cr	205.9Cr	212.7Cr
Per Share Items
Net EPS - Basic	6.81	7.16	8.16	9.94	10.53
Basic EPS - Continuing Operations	6.81	7.16	8.16	9.94	10.53
Basic Weighted Average Shares Outstanding	21Cr	21Cr	21Cr	21Cr	20Cr
Net EPS - Diluted	6.63	6.98	7.97	9.7	10.3
Diluted EPS - Continuing Operations	6.63	6.98	7.97	9.7	10.3
Diluted Weighted Average Shares Outstanding	21Cr	22Cr	22Cr	21Cr	21Cr
Normalized Basic EPS	5.72	6.02	6.88	8.14	8.57
Normalized Diluted EPS	5.57	5.87	6.72	7.94	8.38
Dividend Per Share	1.04	1.36	1.68	1.8	2
Payout Ratio	15.54	18.36	20.41	18.52	19.48
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
Total Revenues (As Reported)	991Cr	1.13TCr	1.3TCr	1.49TCr	1.59TCr
Effective Tax Rate - (Ratio)	21.66	25.37	23.73	21.76	21.33
Current Domestic Taxes	40Cr	50Cr	59Cr	62Cr	59Cr
Current Foreign Taxes	2.5Cr	3.2Cr	3.9Cr	4.1Cr	4.2Cr
Total Current Taxes	42Cr	53Cr	63Cr	66Cr	63Cr
Deferred Domestic Taxes	-3.4Cr	-1.3Cr	-7.5Cr	-8Cr	-4.7Cr
Deferred Foreign Taxes	-30L	-30L	-1.3Cr	-30L	-50L
Total Deferred Taxes	-3.7Cr	-1.6Cr	-8.8Cr	-8.3Cr	-5.2Cr
Normalized Net Income	117.69Cr	126.38Cr	145.81Cr	168.5Cr	173.12Cr
Supplemental Operating Expense Items
Stock-Based Comp., G&A Exp. (Total)	-	19Cr	24Cr	25Cr	25Cr
Stock-Based Comp., Other (Total)	13Cr	-	-	-	-
Total Stock-Based Compensation	13Cr	19Cr	24Cr	25Cr	25Cr

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	720.1Cr	617.8Cr	931.3Cr	1.1TCr	1.14TCr
Cash & Securities Segregated	1.13TCr	848.1Cr	323.5Cr	335Cr	339.8Cr
Securities Purchased Under Agreements To Resell	28Cr	37Cr	19Cr	41Cr	30Cr
Securities Borrowed	20Cr	34Cr	23Cr	34Cr	40Cr
Accounts Receivable, Total	283.1Cr	293.4Cr	252.5Cr	271.1Cr	282.1Cr
Other Receivables	2.69TCr	4.59TCr	4.64TCr	4.9TCr	5.46TCr
Gross Property Plant And Equipment	179.9Cr	193.8Cr	219.1Cr	238.9Cr	161.7Cr
Accumulated Depreciation	-85Cr	-96Cr	-107Cr	-118.6Cr	-68Cr
Net Property Plant And Equipment	94Cr	98Cr	112.1Cr	120.3Cr	94Cr
Goodwill	66Cr	142.2Cr	143.7Cr	145.1Cr	145.1Cr
Other Intangibles, Total	22Cr	51Cr	47Cr	44Cr	71Cr
Investment In Debt and Equity Securities	863Cr	1.01TCr	945.8Cr	854.4Cr	726.1Cr
Trading Asset Securities, Total	85Cr	145.8Cr	39Cr	154.7Cr	158.7Cr
Loans Held For Sale	14Cr	14Cr	14Cr	18Cr	42Cr
Other Current Assets, Total	14Cr	17Cr	127.1Cr	26Cr	24Cr
Deferred Tax Assets Long-Term (Collected)	30Cr	63Cr	71Cr	65Cr	67Cr
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	122.7Cr	138.4Cr	149.2Cr	195.2Cr	206.1Cr
Total Assets	6.19TCr	8.1TCr	7.84TCr	8.3TCr	8.82TCr
Liabilities
Accounts Payable, Total	1.4TCr	1.14TCr	544.7Cr	582.5Cr	585.3Cr
Accrued Expenses, Total	182.5Cr	178.7Cr	191.4Cr	232.5Cr	260.3Cr
Short-Term Borrowings	50Cr	100Cr	83Cr	116.2Cr	130.1Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	10Cr	12Cr	12Cr	13Cr	13Cr
Long-Term Debt	289.5Cr	332.9Cr	313.9Cr	308.9Cr	422Cr
Long-Term Leases	35Cr	36Cr	42Cr	40Cr	40Cr
Current Income Taxes Payable	5.1Cr	2.8Cr	1.7Cr	-	50L
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	51Cr	153Cr	156.4Cr	372.7Cr	2.56TCr
Deferred Tax Liability Non-Current	-	1.4Cr	80L	40L	-
Other Non Current Liabilities	3.34TCr	5.19TCr	5.47TCr	5.47TCr	3.56TCr
Total Liabilities	5.36TCr	7.15TCr	6.82TCr	7.13TCr	7.57TCr
Preferred Stock Convertible	-	12Cr	7.9Cr	7.9Cr	7.9Cr
Total Preferred Equity	-	12Cr	7.9Cr	7.9Cr	7.9Cr
Common Stock, Total	20L	20L	20L	20L	30L
Additional Paid In Capital	208.8Cr	298.7Cr	314.3Cr	325.1Cr	323.5Cr
Retained Earnings	763.3Cr	884.3Cr	1.02TCr	1.19TCr	1.36TCr
Treasury Stock	-143.7Cr	-151.2Cr	-225.2Cr	-305.1Cr	-402.2Cr
Comprehensive Income and Other	-4.1Cr	-98Cr	-97Cr	-50Cr	-40Cr
Total Common Equity	824.5Cr	933.8Cr	1.01TCr	1.16TCr	1.24TCr
Minority Interest	5.8Cr	-2.6Cr	-2.7Cr	-60L	10L
Total Equity	830.3Cr	943.2Cr	1.02TCr	1.17TCr	1.25TCr
Total Liabilities And Equity	6.19TCr	8.1TCr	7.84TCr	8.3TCr	8.82TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	21Cr	22Cr	21Cr	20Cr	20Cr
ECS Total Common Shares Outstanding	21Cr	22Cr	21Cr	20Cr	20Cr
Book Value / Share	40.08	43.41	48.55	57.03	62.7
Tangible Book Value	736.3Cr	740.7Cr	822.8Cr	970.8Cr	1.03TCr
Tangible Book Value Per Share	35.79	34.43	39.41	47.75	51.81
Total Debt	385Cr	480.7Cr	450.5Cr	478.4Cr	605.9Cr
Net Debt	-1.6TCr	-1.2TCr	-885.1Cr	-1.19TCr	-1.1TCr
Equity Method Investments, Total	-	-	-	-	-
Full Time Employees	15T	17T	18T	19T	19.5T

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	140.3Cr	150.9Cr	173.9Cr	206.8Cr	213.5Cr
Depreciation, Depletion & Amortization	5.1Cr	5Cr	5.1Cr	5.8Cr	6.8Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.1Cr	3.3Cr	4.5Cr	4.4Cr	4.1Cr
Total Depreciation, Depletion & Amortization	7.2Cr	8.3Cr	9.6Cr	10Cr	11Cr
Amortization of Deferred Charges, Total	6.2Cr	6.2Cr	6.9Cr	7.7Cr	8.6Cr
(Gain) Loss on Sale of Investments - (CF)	1.5Cr	2.3Cr	-4.9Cr	-3.6Cr	-1.9Cr
Total Asset Writedown	-	-	-	-	-
Provision for Credit Losses	-	-	29Cr	-	-
Stock-Based Compensation (CF)	13Cr	19Cr	24Cr	25Cr	25Cr
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	-2Cr	11Cr	-	2.1Cr	12Cr
Minority Interest in Earnings - (CF)	-	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Operating	-50L	3.3Cr	4.9Cr	-4.1Cr	-20Cr
Change in Accounts Receivable	-42Cr	-20Cr	26Cr	-36Cr	-11Cr
Change in Accounts Payable	728.4Cr	-421.3Cr	-608.8Cr	9.1Cr	70L
Change in Other Net Operating Assets (Collected)	-187.5Cr	226.8Cr	5.8Cr	28Cr	19Cr
Other Operating Activities	-2.3Cr	21Cr	-17Cr	-29Cr	-15Cr
Cash from Operations	662.5Cr	7.2Cr	-351.4Cr	215.5Cr	243.4Cr
Capital Expenditure	-7.4Cr	-9.1Cr	-17Cr	-20Cr	-19Cr
Cash Acquisitions	-27Cr	146.1Cr	-	-	-
Investment in Marketable and Equity Securities, Total	-106.8Cr	-128.1Cr	58Cr	148.5Cr	137.9Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-374Cr	-702.2Cr	-58Cr	-218.4Cr	-546.6Cr
Other Investing Activities, Total	80L	-22Cr	-9.5Cr	-6.4Cr	-4.6Cr
Cash from Investing	-514Cr	-715.1Cr	-27Cr	-97Cr	-432.1Cr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	74Cr	102.5Cr	320Cr	130Cr	223Cr
Total Debt Issued	74Cr	102.5Cr	320Cr	130Cr	223Cr
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-88Cr	-97Cr	-339.1Cr	-135Cr	-109.8Cr
Total Debt Repaid	-88Cr	-97Cr	-339.1Cr	-135Cr	-109.8Cr
Issuance of Common Stock	5.3Cr	5.2Cr	4.6Cr	4.6Cr	3.1Cr
Repurchase of Common Stock	-13Cr	-22Cr	-86Cr	-98Cr	-126.7Cr
Repurchase of Preferred Stock	-	-	-4Cr	-	-
Common Dividends Paid	-22Cr	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-28Cr	-36Cr	-38Cr	-42Cr
Common & Preferred Stock Dividends Paid	-22Cr	-28Cr	-36Cr	-38Cr	-42Cr
Other Financing Activities, Total	568.5Cr	626.2Cr	284Cr	180.9Cr	288.1Cr
Cash from Financing	525.4Cr	587.9Cr	143.8Cr	44Cr	236.1Cr
Foreign Exchange Rate Adjustments	7.6Cr	-59Cr	24Cr	18Cr	-3.5Cr
Net Change in Cash	681.5Cr	-179Cr	-211.1Cr	180Cr	44Cr
Supplemental Items
Cash Interest Paid	14Cr	32Cr	131Cr	211.9Cr	185.3Cr
Cash Income Tax Paid (Refund)	44Cr	52Cr	56Cr	66Cr	65Cr
Net Debt Issued / Repaid	-14Cr	5.8Cr	-19Cr	-5Cr	113.2Cr

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.57	2.11	2.18	2.56	2.49
Return On Equity %	18.13	17.02	17.73	18.93	17.67
Return on Common Equity	18.24	17.08	17.75	18.95	17.71
Margin Analysis
Gross Profit Margin %	94.3	93.91	93.48	93.42	93.06
SG&A Margin	71.72	73.12	68.39	69.31	69.85
Income From Continuing Operations Margin %	14.3	13.97	15.11	16.16	15.23
Net Income Margin %	14.3	13.97	15.11	16.16	15.23
Net Avail. For Common Margin %	14.28	13.91	15.01	16.09	15.18
Normalized Net Income Margin	11.99	11.7	12.67	13.17	12.35
Asset Turnover
Asset Turnover	0.18	0.15	0.14	0.16	0.16
Short Term Liquidity
Current Ratio	2.94	4.15	6.44	5.22	2.12
Quick Ratio	2.92	4.13	6.3	5.19	2.1
Operating Cash Flow to Current Liabilities	0.39	0	-0.36	0.16	0.07
Long Term Solvency
Total Debt/Equity	46.37	50.96	44.22	41	48.46
Total Debt / Total Capital	31.68	33.76	30.66	29.08	32.64
LT Debt/Equity	39.06	39.16	34.94	29.95	36.99
Long-Term Debt / Total Capital	26.68	25.94	24.22	21.24	24.92
Total Liabilities / Total Assets	86.58	88.35	87	85.94	85.83
Tier 1 Capital Ratio %	25	19.2	21.4	22.8	23
Total Capital Ratio %	26.2	20.4	22.8	24.1	24.1
Leverage Ratio %	12.6	10.3	11.9	12.8	13.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.5	10.07	6.31	11.18	9.52
Gross Profit, 1 Yr. Growth %	27.41	9.61	5.81	11.09	9.09
Earnings From Cont. Operations, 1 Yr. Growth %	71.52	7.56	15.24	18.92	3.24
Net Income, 1 Yr. Growth %	71.52	7.56	15.24	18.92	3.24
Normalized Net Income, 1 Yr. Growth %	67.38	8.48	9.22	15.56	2.74
Diluted EPS Before Extra, 1 Yr. Growth %	70.88	5.28	14.18	21.71	6.19
Common Equity, 1 Yr. Growth %	15.9	13.26	8.54	14.4	7.16
Total Assets, 1 Yr. Growth %	30.35	30.8	-3.2	5.91	6.31
Tangible Book Value, 1 Yr. Growth %	13.03	0.6	11.08	17.99	9.14
Cash From Operations, 1 Yr. Growth %	63.42	-98.92	-4.98T	-161.33	12.95
Capital Expenditures, 1 Yr. Growth %	-40.32	22.97	90.11	18.5	-8.29
Dividend Per Share, 1 Yr. Growth %	5.05	30.77	23.53	7.14	11.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.94	18	8.3	8.72	10.35
Gross Profit, 2 Yr. CAGR %	13.17	18.17	7.83	8.43	10.08
Earnings From Cont. Operations, 2 Yr. CAGR %	16.48	35.82	11.33	17.07	10.8
Net Income, 2 Yr. CAGR %	16.48	35.82	11.33	17.07	10.8
Normalized Net Income, 2 Yr. CAGR %	16.39	35.7	9.38	12.35	8.96
Diluted EPS Before Extra, 2 Yr. CAGR %	17.77	34.13	9.64	17.88	13.68
Common Equity, 2 Yr. CAGR %	11.93	14.57	10.87	11.43	10.72
Total Assets, 2 Yr. CAGR %	26.25	30.57	12.52	1.25	6.11
Tangible Book Value, 2 Yr. CAGR %	11.06	6.63	5.71	14.48	11.7
Cash From Operations, 2 Yr. CAGR %	238.85	-86.7	-27.29	447.09	-16.77
Capital Expenditures, 2 Yr. CAGR %	-26.77	-14.33	52.9	50.09	4.25
Dividend Per Share, 2 Yr. CAGR %	6.9	17.21	27.1	15.04	9.11
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.69	11.98	14.06	9.25	8.98
Gross Profit, 3 Yr. CAGR %	10.86	11.97	14	8.91	8.65
Earnings From Cont. Operations, 3 Yr. CAGR %	17.86	13.43	28.58	13.81	12.26
Net Income, 3 Yr. CAGR %	17.86	13.43	28.58	13.81	12.26
Normalized Net Income, 3 Yr. CAGR %	12.71	13.31	28.56	11.4	9.05
Diluted EPS Before Extra, 3 Yr. CAGR %	20.04	13.45	27.12	13.52	13.85
Common Equity, 3 Yr. CAGR %	8.99	12.37	12.52	12.03	9.99
Total Assets, 3 Yr. CAGR %	18.27	27.75	18.17	10.27	2.91
Tangible Book Value, 3 Yr. CAGR %	8.72	7.45	8.1	9.65	11.49
Cash From Operations, 3 Yr. CAGR %	95.69	-50.03	-4.8	-31.3	223.34
Capital Expenditures, 3 Yr. CAGR %	-17.96	-12.96	11.74	40.45	27.36
Dividend Per Share, 3 Yr. CAGR %	12.35	14.33	19.28	20.06	13.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.77	11.11	9.73	10.71	12.56
Gross Profit, 5 Yr. CAGR %	12.92	11.06	9.64	10.59	12.42
Earnings From Cont. Operations, 5 Yr. CAGR %	21.01	18.86	15.2	14.87	21.15
Net Income, 5 Yr. CAGR %	21.52	18.86	15.2	14.87	21.15
Normalized Net Income, 5 Yr. CAGR %	17.67	15.38	12.15	14.17	20.33
Diluted EPS Before Extra, 5 Yr. CAGR %	22.17	19.31	15.76	15.2	21.56
Common Equity, 5 Yr. CAGR %	10.89	10.84	9.74	11.99	11.8
Total Assets, 5 Yr. CAGR %	14.47	18.34	15.93	16.41	13.19
Tangible Book Value, 5 Yr. CAGR %	10.78	7.8	7.51	10.21	9.52
Cash From Operations, 5 Yr. CAGR %	63.14	-10.45	31.79	30.15	-9.78
Capital Expenditures, 5 Yr. CAGR %	-9.48	-13.69	5.24	8.24	8.68
Dividend Per Share, 5 Yr. CAGR %	14.29	18.31	18.03	14.62	15.1